CITIZENS FINANCIAL GROUP INC/RI
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 759944
PROVIDENCE, RI
Position in VRTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$25,327,269
+$3,078,861 QoQ
Shares Held
50,988
+2.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#230
of 1,735 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIZENS FINANCIAL GROUP INC/RI holds $49,704,895 across 22 Biotechnology names. VRTX ranks #1 (51.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
50,988 | $25,327,269 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
74,036 | $13,865,462 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,376 | $2,728,611 | |
| 4 | ABCL |
AbCellera Biologics Inc.
|
211,890 | $1,663,336 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,682 | $1,108,392 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
35,148 | $921,580 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,793 | $478,427 | |
| 8 | RPRX |
Royalty Pharma plc
|
7,827 | $438,859 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,327,269 | 50,988 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $22,248,408 | 49,824 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $19,677,183 | 43,403 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $16,793,914 | 42,881 | Shares | Defined | 2025-10-24 | |
| 2025-06-30 | $14,655,093 | 32,918 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $11,058,743 | 22,810 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $9,138,873 | 22,694 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $10,286,174 | 22,117 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $13,814,584 | 29,473 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $12,278,624 | 29,374 | Shares | Defined | 2024-05-17 | |
| 2023-12-31 | $12,123,693 | 29,796 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $10,473,580 | 30,119 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,128,097 | 31,622 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $13,604,407 | 43,179 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $12,686,105 | 43,930 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $13,231,977 | 45,700 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $12,815,245 | 45,478 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $12,497,591 | 47,889 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $10,430,999 | 47,500 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $818,613 | 4,513 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $164,024 | 565 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $144,434 | 607 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||